Arbutus Biopharma (NASDAQ:ABUS) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Arbutus Biopharma beat estimated earnings by 21.05%, reporting an EPS of $-0.15 versus an estimate of $-0.19.

Revenue was up $820.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 10.31% drop in the share price the next day.

Here's a look at Arbutus Biopharma's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.